Global Health Limited (MEDANTA) — Financial Results Announcement

· NSE 🔴 High Importance Neutral
Revenue: ₹37,093.78 CrNet Profit: ₹4,962.01 Cr
📢 Key Event
Board approves FY2026 results, final dividend, and new senior management appointments.
🔄 What Changed
Final dividend recommended at ₹0.50 per share; new CMGO and General Counsel appointed; SMP Richa Singh resigns effective May 20.
🔮 What's Next
None
💡 Investor Takeaway
Shareholders receive a proposed dividend while leadership changes signal strategic growth focus.

Global Health Limited reported FY2026 total income of **₹38,157.86 crores** and profit after tax of **₹4,962.01 crores**, approved a final dividend of **₹0.50 per share** (25% of face value), and appointed Kedar Ashok Apte as Chief Marketing & Growth Officer and Jagdeep Singh as General Counsel effective May 14, 2026.

📄 View Original Announcement (PDF)

About Global Health Limited (MEDANTA)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹33,404.85 Cr P/E: 65.8

View full MEDANTA stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.